相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
Antonina V. Kurtova et al.
NATURE (2015)
Roles of microsomal prostaglandin E synthase-1 in lung metastasis formation in prostate cancer RM9 cells
R. Takahashi et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
AR function in promoting metastatic prostate cancer
Michael A. Augello et al.
CANCER AND METASTASIS REVIEWS (2014)
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
Thordur Oskarsson et al.
CELL STEM CELL (2014)
Validation of Stem Cell markers in Clinical Prostate Cancer: α6-Integrin is Predictive for Non-Aggressive Disease
A. Marije Hoogland et al.
PROSTATE (2014)
β1 Integrin Targeting Potentiates Antiangiogenic Therapy and Inhibits the Growth of Bevacizumab-Resistant Glioblastoma
W. Shawn Carbonell et al.
CANCER RESEARCH (2013)
Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation
Weixiao Sha et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Differential stem- and progenitor-cell trafficking by prostaglandin E2
Jonathan Hoggatt et al.
NATURE (2013)
OPINION The link between benign prostatic hyperplasia and prostate cancer
David D. Orsted et al.
NATURE REVIEWS UROLOGY (2013)
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Lisa M. Coussens et al.
SCIENCE (2013)
Molecular Pathogenesis and Progression of Prostate Cancer
Randy Schrecengost et al.
SEMINARS IN ONCOLOGY (2013)
NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
R. Nanta et al.
ONCOGENESIS (2013)
Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients
Irene V. Bijnsdorp et al.
JOURNAL OF EXTRACELLULAR VESICLES (2013)
Expression and Significance of Microsomal Prostaglandin Synthase-1 (mPGES-1) and Beclin-1 in the Development of Prostate Cancer
Lu-Wei Xu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07)
Richard Cathomas et al.
CLINICAL CANCER RESEARCH (2012)
Targeting the EGFR signaling pathway in cancer therapy
Parthasarathy Seshacharyulu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity
S. Donnini et al.
ONCOGENE (2012)
Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis
D. Lu et al.
ONCOGENE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
α1 and β1 integrins enhance the homing and differentiation of cultured prostate cancer stem cells
Satyanarayana Rentala et al.
ASIAN JOURNAL OF ANDROLOGY (2010)
Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis
Daisuke Kamei et al.
BIOCHEMICAL JOURNAL (2010)
Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
George J. Klarmann et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells
Hiromi Hanaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naive Castration-resistant Prostate Cancer: Final Results of a Phase II Trial
Chadi Nabhan et al.
UROLOGY (2009)
Results from a monocentric phase II trial of erlotinib in patients with metastatic prostate cancer
G. Gravis et al.
ANNALS OF ONCOLOGY (2008)
The epidermal growth factor receptor family: Biology driving targeted therapeutics
M. J. Wieduwilt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation
Daigen Xu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer
Thorsten Schlomm et al.
CLINICAL CANCER RESEARCH (2007)
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways
Sandra Donnini et al.
FASEB JOURNAL (2007)
Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats
Peter Hammarsten et al.
PROSTATE (2007)
Cyclooxygenase-2-dependent regulation of E-cadherin:: Prostaglandin E2 induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer
Mariam Dohadwala et al.
CANCER RESEARCH (2006)
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis
MD Castellone et al.
SCIENCE (2005)
Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group
CM Canil et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
JI Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Simultaneous expression of COX-2 and mPGES-1 in mouse gastrointestinal hamartomas
H Takeda et al.
BRITISH JOURNAL OF CANCER (2004)
Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines
BP van Rees et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor
FG Buchanan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms
S Mohan et al.
JOURNAL OF ENDOCRINOLOGY (2002)